Banner Health Hits 50 Implants with SynCardia’s Total Artificial Heart — Picard Medical, Inc.

Event summary

Banner Health has performed over 50 implants of the SynCardia Total Artificial Heart (STAH), making it one of the busiest programs globally.
The program is led by Francisco Arabia, M.D., part of Banner Health’s Advanced Heart Failure Program.
Picard Medical highlights Banner Health’s expertise in managing advanced biventricular heart failure patients.
Over 2,100 STAH implants have been performed worldwide, with the longest support duration exceeding eight years.
Picard Medical is developing the Emperor Total Artificial Heart, a next-generation fully implantable device.

The big picture

Banner Health’s achievement underscores the growing clinical validation of total artificial heart technology, particularly as a bridge-to-transplant solution. With over 6 million adults in the U.S. living with heart failure and a persistent shortage of donor hearts, the demand for advanced mechanical circulatory support devices is poised to rise. Picard Medical’s focus on developing next-generation devices like the Emperor Total Artificial Heart could further solidify its leadership in this niche but critical segment of the medical device market.

What we're watching

Clinical Adoption: How the pace of STAH implants at Banner Health will influence broader adoption of total artificial heart technology.
Regulatory Approvals: Whether the Emperor Total Artificial Heart will secure regulatory approvals and expand market access.
Technological Advancements: The impact of next-generation fully implantable devices on long-term patient outcomes and market dynamics.